163 related articles for article (PubMed ID: 11705397)
1. Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor.
Cain SA; Coughlan T; Monk PN
Biochemistry; 2001 Nov; 40(46):14047-52. PubMed ID: 11705397
[TBL] [Abstract][Full Text] [Related]
2. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
Crass T; Bautsch W; Cain SA; Pease JE; Monk PN
Biochemistry; 1999 Jul; 38(30):9712-7. PubMed ID: 10423250
[TBL] [Abstract][Full Text] [Related]
3. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN
Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387
[TBL] [Abstract][Full Text] [Related]
4. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
Monk PN; Barker MD; Partridge LJ; Pease JE
J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
[TBL] [Abstract][Full Text] [Related]
5. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
[TBL] [Abstract][Full Text] [Related]
6. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
[TBL] [Abstract][Full Text] [Related]
7. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
[TBL] [Abstract][Full Text] [Related]
9. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
10. Selection of novel ligands from a whole-molecule randomly mutated C5a library.
Cain SA; Williams DM; Harris V; Monk PN
Protein Eng; 2001 Mar; 14(3):189-93. PubMed ID: 11342716
[TBL] [Abstract][Full Text] [Related]
11. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs.
DeMartino JA; Van Riper G; Siciliano SJ; Molineaux CJ; Konteatis ZD; Rosen H; Springer MS
J Biol Chem; 1994 May; 269(20):14446-50. PubMed ID: 8182049
[TBL] [Abstract][Full Text] [Related]
12. Site directed mutagenesis of the complement C5a receptor--examination of a model for its interaction with the ligand C5a.
Pease JE; Burton DR; Barker MD
Mol Immunol; 1994 Jul; 31(10):733-7. PubMed ID: 8035835
[TBL] [Abstract][Full Text] [Related]
13. Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site.
Higginbottom A; Cain SA; Woodruff TM; Proctor LM; Madala PK; Tyndall JD; Taylor SM; Fairlie DP; Monk PN
J Biol Chem; 2005 May; 280(18):17831-40. PubMed ID: 15661745
[TBL] [Abstract][Full Text] [Related]
14. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
15. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
Christophe T; Rabiet MJ; Tardif M; Milcent MD; Boulay F
J Biol Chem; 2000 Jan; 275(3):1656-64. PubMed ID: 10636859
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
17. C5L2, a nonsignaling C5A binding protein.
Okinaga S; Slattery D; Humbles A; Zsengeller Z; Morteau O; Kinrade MB; Brodbeck RM; Krause JE; Choe HR; Gerard NP; Gerard C
Biochemistry; 2003 Aug; 42(31):9406-15. PubMed ID: 12899627
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the C5a anaphylatoxin core domain using a C5a phage library selected on differentiated U937 cells.
Kola A; Baensch M; Bautsch W; Klos A; Köhl J
Mol Immunol; 1999 Feb; 36(2):145-52. PubMed ID: 10378686
[TBL] [Abstract][Full Text] [Related]
19. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
Mery L; Boulay F
J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
[TBL] [Abstract][Full Text] [Related]
20. Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain.
Naik N; Giannini E; Brouchon L; Boulay F
J Cell Sci; 1997 Oct; 110 ( Pt 19)():2381-90. PubMed ID: 9410877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
